FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

96037004: Roxithromycin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
159075010 Roxithromycin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
840316015 Roxithromycin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
939871000195114 roxitromicina it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
838971000172111 roxithromycine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Roxithromycin Is a Medicinal product containing macrolide and acting as antibacterial agent (product) false Inferred relationship Some
Roxithromycin Is a Substance with macrolide structure and antibacterial mechanism of action (substance) true Inferred relationship Some
Roxithromycin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Roxithromycin Is a Macrolide (substance) false Inferred relationship Some
Roxithromycin Is a Antibacterial false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing roxithromycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Roxithromycin Inferred relationship Some 1
Product containing only roxithromycin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Roxithromycin Inferred relationship Some 1
Product containing only roxithromycin in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Roxithromycin Inferred relationship Some 1
Product containing precisely roxithromycin 150 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Roxithromycin Inferred relationship Some 1
Product containing precisely roxithromycin 150 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Roxithromycin Inferred relationship Some 1
Roxithromycin-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Roxithromycin Inferred relationship Some 1

This concept is not in any reference sets

Back to Start